Unlocking Unstructured Data with AI for Optimized Protocol Development
Unlocking Unstructured Data with AI for Optimized Protocol Development In this podcast episode, Mike Eckrote, Senior Vice President of Strategic
AI
Insights on the FDA’s ELSA AI And What Changes Next
Traditional clinical trial designs often delay progress due to rigid protocols and frequent amendments. Adaptive and platform trial models introduce flexibility and shared infrastructure, reducing startup delays, cutting costs, and enabling sponsors to conduct faster, more efficient research.
Advarra’s Perspective on FDA’s Draft AI Guidance: Advancing Responsible Innovation
The U.S. Food and Drug Administration’s (FDA’s) recent draft guidance, “Considerations for the Use of Artificial Intelligence to Support Regulatory
The Story Behind Braid: How the Brand Reflects Advarra’s Vision for Data and AI in Clinical Research
Advarra partnered with PreHealth, a brand growth and experience agency, to create Braid, the identity for Advarra’s data and AI
Understanding the Impact of the New EU Artificial Intelligence Act on Clinical Research
Artificial intelligence (AI) has taken the world by storm – and regulators are paying attention. The European Parliament recently adopted